A key partner for healthcare professionals

  • French laboratory

  • In-house products developed by our R&D team

  • A team of 50 sales representatives throughout France

  • Certified products

our products

Focus on

Urinary infection BIOSYNEX

Urinary infection self-test

Biosynex Urinary Infection Test Strips are equipped with reagent zones. They allow you to quickly check several parameters.

During a cystitis, bacterial proliferation can lead to the presence of certain cells and substances in the urine. For example, the immune system’s reaction to the bacteria may result in the presence of a large number of leukocytes in the urine.

Read more

Talking about us

In the press

  • chembio logo biosynex
    2 May 2023

    SEC CHEMBIO documents

    Documents filed with the SEC. Acquisition of CHEMBIO DIAGNOSTICS:

  • chembio logo biosynex
    15 March 2023

    Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

    Find out more about BIOSYNEX and CHEMBIO: • Project Merci – Schedule to tender offert statement under section 14(d)(1) or 13(e)(1) of the securities exchange...

  • 17 January 2023

    Extension of the distribution agreement between Credo Diagnostics Biomedical Pte Ltd and BIOSYNEX S.A.

    « BIOSYNEX and Credo Diagnostics have recently strengthened their collaboration by signing an exclusivity agreement for an extended territory including the United Kingdom. Thanks to...

  • 4 January 2023

    Biosynex announces the acquisition of a 75% stake in Danish company Medkoncept AS

    As part of its international development, BIOSYNEX announces that it has acquired a 75% majority stake,alongside the two founders, in MEDKONCEPT AS, a company based...

  • 20 April 2022

    Biosynex has acquired Parakito

    « Biosynex has acquired PARAKITO, operated by Hong-Kong based Evergreen Land LTD. The transaction includes assets and IP and the exclusive right to commercialize the...

  • 13 January 2022

    Theradiag Announces That Biosynex Has Filed a Voluntary Takeover Bid for Its Shares

    « Theradiag, a company specializing in in vitro diagnostics and Theranostics, announces that Biosynex has filed with the French financial markets authority (the “Autorité des...